BRCA2 and ductal breast carcinoma in situ: Although the number of BRCA2 mutation-related cases with DCIS and invasive lesions was small, there was a trend towards higher expression of the hypoxia-related markers in BRCA2 mutation-related DCIS as compared to the invasive lesions.